Abattis Bioceuticals Corp. Stock Canadian Securities Exchange
Equities
ATT
CA00258G1037
Healthcare Facilities & Services
Sales 2018 | 8.37K 6.13K | Sales 2019 | 357K 261K | Capitalization | 8.62M 6.31M |
---|---|---|---|---|---|
Net income 2018 | -78M -57.09M | Net income 2019 | -3M -2.2M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.66M | Net cash position 2019 | 2.25M 1.65M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 19-03-31 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 18-10-18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Director of Finance/CFO | - | 19-03-31 |
1st Jan change | Capi. | |
---|---|---|
+31.96% | 264M | |
+31.69% | 251M | |
+47.97% | 193M | |
+39.96% | 125M | |
-41.31% | 122M | |
-28.57% | 121M | |
+115.91% | 120M | |
+7.69% | 83.42M | |
+150.00% | 75.33M |